Scigenomics

India
Provides genetic testing, DNA analysis, and health products for medical research and consultations.

About Scigenomics

Scigenomics is a Healthcare company based in India. It provides genetic testing, DNA analysis, and health products for medical research and consultations. It operates on a B2C and B2B model. Its Indian entity Scigenomics Private Limited reported revenue of β‚Ή41.9 Lakh. Scigenomics offers products and services including Microbiome Testing, Whole Genome Testing, Nadcell Plus, and TQLC. Its focus areas include Medical Research, Diagnostic Services, Microbiome Analysis and Biotechnology. Its competitors include Viome, Flore, Evvy, Carbiotix and BIOMES and 5 more; 7 of its 10 listed competitors have raised funding.

Company details

SciGenomics specializes in genetic and DNA testing services to deliver healthcare solutions through cutting-edge technology. They conduct tests like whole genome sequencing and microbiome analysis to identify disease risks and provide personalized advice. Based in Mumbai and Navi Mumbai, India, they partner with institutions and offer products such as anti-aging supplements. Their activities focus on diagnostics, research, and direct consumer services to improve health outcomes.

  • Headquarters India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website scigenomics.com
  • Social LinkedIn X Facebook Instagram
  • Legal Name Scigenomics Pvt. Ltd.
  • Date of Incorporation 05 Aug, 2019
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹41.9 Lakh

    FY 2024 · +556% YoY

  • Net Profit
    ₹8 Lakh

    FY 2024 · 19% margin

  • EBITDA
    ₹14.2 Lakh

    FY 2024 · 34% margin

Products & Services of Scigenomics

Scigenomics offers a comprehensive portfolio of products and services, including Microbiome Testing, Whole Genome Testing, Nadcell Plus, and TQLC.

Microbiome Testing
Genetic Services

Analyzes gut microbiome for health insights and disease detection.

Whole Genome Testing
Genetic Services

Sequences full genome to identify genetic disorders and risks.

Nadcell Plus
Health Supplements

Anti-aging supplement based on genetic testing results.

TQLC
Health Products

Nutritional supplement for overall wellness and genetic support.

Board of directors of Scigenomics Private Limited (Scigenomics)

Scigenomics Private Limited is the primary company behind Scigenomics. The board of Scigenomics Private Limited currently have 2 directors; the longest-serving is Varun Bhagat Singh Singh, appointed in 2019. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Varun Bhagat Singh Singh
DIN 07658077
Director05 Aug 20197 yrs 2 moScigenomics Private Limited
Nisha Bhagatsingh Rajput
DIN 10629184
Director16 May 20242 yrs 5 moScigenomics Private Limited

Financials of Scigenomics

Figures of Scigenomics Private Limited, the primary company behind Scigenomics, for FY 2024. Revenue was ₹41.9 Lakh (+556% year on year). Net profit was ₹8 Lakh (19% margin). EBITDA was ₹14.2 Lakh (34% margin).

  • ₹41.9 LakhRevenue · FY 2024 · +556% YoY
  • ₹8 LakhNet profit · 19% margin
  • ₹14.2 LakhEBITDA · 34% margin
  • ₹25 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Scigenomics Private Limited are on its company page.

Premium access

Detailed financial statements for Scigenomics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Scigenomics

Scigenomics has 10 listed competitors in our database, 7 of them funded. They include Viome, Flore, Evvy, Carbiotix and BIOMES, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
viome.com2016Los Alamos, United States$301.57M136
Machine learning-based bioinformatics solutions for health insights are provided.
flore.com2016San Diego, United States$21.12M–
Customized probiotics for gut health are provided via stool analysis.
evvy.com2002New York, United States$19M9
Vaginal microbiome test kits are provided through an online platform.
carbiotix.com2014Lund, Sweden––
Prebiotic ingredients and consumer products for microbiome health are developed.
biomes.world2017Wildau, Germany$2.17M45
Gut health diagnostics via home-based genetic testing are provided.
ubiome.com2012San Francisco, United States$109.62M33
Provides comprehensive sequence datasets for human microbiome research and analysis.
mybioma.com2018Langenzersdorf, Austria––
Provider of internet first brand of gut microbiome analysis kit
juno.bio2018London, United Kingdom–5
Microbiome-focused research services are provided by Juno Bio.
genefitletics.com2019Delhi, India$23,587–
Early detection tests for metabolic diseases and cancer are offered.
microbiotx.com2022Bengaluru, India$254,059–
Gut-microbiome solutions for personalized wellness are provided.
Premium access

Detailed competitors of Scigenomics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Microbiome Therapeutics

10 companies that operate in the same segment as Scigenomics (Microbiome Therapeutics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Biosolutions and enzymes are developed for biotechnology applications across industries.
2000Bags Sword, Denmark–––
Pendulum is focused on developing advanced probiotic solutions.
2012San Francisco, California, United StatesUSD 109.5 M–55
Gut microbiome insights, analytics, tests, and therapeutics are provided.
2019Singapore, SingaporeUSD 10.5 MUSD 1.37 M–
Microbiome-based therapeutics for skin conditions like eczema are developed.
2014Farmington, United StatesUSD 37.4 M–12
Engineered microbes are developed as programmable therapeutics for metabolic disorders.
2013Cambridge, Massachusetts, United StatesUSD 34.4 MUSD 8 K1
Therapeutics for infectious and autoimmune diseases are developed.
2010Cambridge, Massachusetts, United StatesUSD 470.49 M–71
Biological drugs for skin and mucosa wound treatment are developed.
2016Uppsala, Uppsala County, SwedenUSD 4.02 MUSD 1.12 M–
Microbiome-based therapeutics for gut diseases are developed.
2017Edinburgh, Scotland, United KingdomUSD 72.96 M–65
The gut-brain axis is explored for therapeutic and nutritional innovations.
2014New York, New York, United StatesUSD 479 M–84
Microbiome therapeutics are developed to address diverse diseases.
2010Cambridge, Massachusetts, United StatesUSD 257.13 MUSD 789 K103
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Scigenomics

Scigenomics is headquartered in India.

The primary company behind Scigenomics, Scigenomics Private Limited, reported revenue of β‚Ή41.9 Lakh for FY 2024, up 556% year on year.

SciGenomics specializes in genetic and DNA testing services to deliver healthcare solutions through cutting-edge technology. They conduct tests like whole genome sequencing and microbiome analysis to identify disease risks and provide personalized advice. Based in Mumbai and Navi Mumbai, India, they partner with institutions and offer products such as anti-aging supplements. Their activities focus on diagnostics, research, and direct consumer services to improve health outcomes.

Scigenomics's top competitors include Viome, Evvy and Flore.

Scigenomics offers Microbiome Testing, Whole Genome Testing, Nadcell Plus, and TQLC.

Scigenomics operates through Scigenomics Private Limited.

The legal entities of Scigenomics currently have 2 directors, including Nisha Bhagatsingh Rajput, Varun Bhagat Singh Singh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available